Methylselenocysteine – a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs-Reference-Cited by-同舟云学术

Methylselenocysteine – a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs

Published:2011-04-07 Issue:6 Volume:8 Page:749-763
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Bhattacharya Arup

Publisher

Informa Healthcare

Subject

Pharmaceutical Science

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425247.2011.571672

Reference104 articles.

1. Cancer Statistics, 2009

2. Why does cytotoxic chemotherapy cure only some cancers?

3. Architectural Heterogeneity in Tumors Caused by Differentiation Alters Intratumoral Drug Distribution and Affects Therapeutic Synergy of Antiangiogenic Organoselenium Compound

4. Lack of Microvessels in Well-Differentiated Regions of Human Head and Neck Squamous Cell Carcinoma A253 Associated with Functional Magnetic Resonance Imaging Detectable Hypoxia, Limited Drug Delivery, and Resistance to Irinotecan Therapy

5. Selenium and anticarcinogenesis: underlying mechanisms

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic engineering of Escherichia coli for seleno-methylselenocysteine production;Journal of Biotechnology;2024-11

2. Novel phenoxy-((phenylethynyl) selanyl) propan-2-ol derivatives as potential anticancer agents;BMC Chemistry;2023-11-28

3. Identification of altered metabolic functional components using metabolomics to analyze the different ages of fruiting bodies of Sanghuangporus vaninii cultivated on cut log substrates;Frontiers in Nutrition;2023-08-03

4. Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy;International Journal of Molecular Sciences;2023-01-04

5. Implication of methylselenocysteine in combination chemotherapy with gemcitabine for improved anticancer efficacy;European Journal of Pharmaceutical Sciences;2022-09